Aklog Lishan 4
4 · Lucid Diagnostics Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Aklog Lishan
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-02-20+2,170,000→ 3,636,627 total
Footnotes (1)
- [F1]Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Signature
/s/ Michael A. Gordon, by power of attorney|2026-02-24